Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Surgeons at Mass Eye and Ear in Boston have found a creative way to make their skin cancer patients look good as new. Our ...

S, Principal Investigator at A*STAR SRL are co-authors of the study. While the current study focuses on basal cell carcinoma (BCC), researchers believe the technology could also be adapted to ...

INVESTIGATORS AND CLINICIANS anticipate that the next wave of therapeutic approaches in renal cell carcinoma (RCC) will target hypoxia-inducible factor-2 (HIF-2), a transcription factor that is ...

In 2016, 252,500 new cases of EC were diagnosed, and 193,900 patients died from EC in China (2). Squamous cell carcinoma (SCC) is the main histological subtype in China, making up around 90% of newly ...

in the treatment of basal cell carcinoma (BCC), with positive data outcomes. The study included patients who had relapsed after standard therapies and had no other treatment options. Among them, three ...

docent at the Department of Cell and Molecular Biology, Karolinska Institutet, Sweden. "You could say that we have created a family tree for the cells of the nervous system and the inner ear." ...

CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable ...

CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable ...